A carregar...
Pioglitazone vs. Glimepiride on Coronary Artery Calcium Progression in Type 2 Diabetes: A Secondary Endpoint of the CHICAGO Study
OBJECTIVE: The CHICAGO (Carotid Intima-Media Thickness in Atherosclerosis Using Pioglitazone) study demonstrated that pioglitazone (PIO) significantly decreased Carotid Intimal Media Thickness (CIMT) progression compared to glimepiride (GLM) in patients with Type 2 diabetes mellitus (T2DM). A second...
Na minha lista:
| Main Authors: | , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2010
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2945383/ https://ncbi.nlm.nih.gov/pubmed/20576945 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/ATVBAHA.110.207696 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|